Assessment of Hearing Loss in Patients with Type 2 Diabetes Mellitus Using Pure Tone Audiometry
Journal of Biomedical and Pharmaceutical Research · 30.06.2026 · 9 (3)
DOI: 10.32553/nrbr4q22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical and Pharmaceutical Research, online erschienen am 30.06.2026. Verfasst von Darshan S Thakare. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background: Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder associated with various microvascular and neuropathic complications. Sensorineural hearing loss (SNHL) has emerged as a potential but often overlooked complication of diabetes. Hyperglycemia may damage the cochlear microvasculature and auditory nerve, resulting in impaired hearing. Materials and Methods: A cross-sectional analytical study was conducted among 100 patients diagnosed with Type 2 Diabetes Mellitus attending the Department of Medicine and ENT. Detailed clinical history, duration of diabetes, and glycemic status were recorded. HbA1c levels were estimated using High-Performance Liquid Chromatography (HPLC). Hearing assessment was performed using Pure Tone Audiometry. Patients were categorized into controlled diabetes (HbA1c
Zitieren
APA
Thakare, D. S. (2026). Assessment of Hearing Loss in Patients with Type 2 Diabetes Mellitus Using Pure Tone Audiometry. Journal of Biomedical and Pharmaceutical Research, 9(3). https://doi.org/10.32553/nrbr4q22
Vancouver
Thakare DS. Assessment of Hearing Loss in Patients with Type 2 Diabetes Mellitus Using Pure Tone Audiometry. Journal of Biomedical and Pharmaceutical Research. 2026;9(3). doi:10.32553/nrbr4q22
BibTeX
@article{Thakare2026,
author = {Thakare, Darshan S},
title = {Assessment of Hearing Loss in Patients with Type 2 Diabetes Mellitus Using Pure Tone Audiometry},
journal = {Journal of Biomedical and Pharmaceutical Research},
year = {2026},
volume = {9},
number = {3},
doi = {10.32553/nrbr4q22}
}
EUVIMED